Pivot Archive
All pivots
Medium Biosciences logo

Medium Biosciences

S21
6 people|Active|Website
Artificial IntelligenceMachine LearningBiotech
47°Significant Pivot
Before

AI-designed Protein Therapeutics

After

AI-designed Affinity Reagents

Full description — before

We develop AI models & new assays to create functional, therapeutic proteins.

Full description — after

Custom affinity reagents, designed for your target and application! We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.

Category shift
Biotech & Drug DiscoveryAI Coding Assistants
Summary

The company shifted from using AI to design therapeutic proteins (for treatment) to designing custom affinity reagents (for research/diagnostic tools), representing a meaningful market change from therapeutics to diagnostics/research tools.

Detected 1 month ago · 2026-05-02